ArticleJournal of cancer research and clinical oncology2015

Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.

Lamprini Stamati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.